Semaglutide showdown: Natco challenges Novo Nordisk patent
Natco’s escalates the legal battle over semaglutide, one of the world’s most valuable and closely contested pharmaceutical drugs.
Natco’s escalates the legal battle over semaglutide, one of the world’s most valuable and closely contested pharmaceutical drugs.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
